310 related articles for article (PubMed ID: 30898653)
1. New Noonan syndrome model mice with RIT1 mutation exhibit cardiac hypertrophy and susceptibility to β-adrenergic stimulation-induced cardiac fibrosis.
Takahara S; Inoue SI; Miyagawa-Tomita S; Matsuura K; Nakashima Y; Niihori T; Matsubara Y; Saiki Y; Aoki Y
EBioMedicine; 2019 Apr; 42():43-53. PubMed ID: 30898653
[TBL] [Abstract][Full Text] [Related]
2. A novel heterozygous RIT1 mutation in a patient with Noonan syndrome, leukopenia, and transient myeloproliferation-a review of the literature.
Nemcikova M; Vejvalkova S; Fencl F; Sukova M; Krepelova A
Eur J Pediatr; 2016 Apr; 175(4):587-92. PubMed ID: 26518681
[TBL] [Abstract][Full Text] [Related]
3. Gain-of-function mutations in RIT1 cause Noonan syndrome, a RAS/MAPK pathway syndrome.
Aoki Y; Niihori T; Banjo T; Okamoto N; Mizuno S; Kurosawa K; Ogata T; Takada F; Yano M; Ando T; Hoshika T; Barnett C; Ohashi H; Kawame H; Hasegawa T; Okutani T; Nagashima T; Hasegawa S; Funayama R; Nagashima T; Nakayama K; Inoue S; Watanabe Y; Ogura T; Matsubara Y
Am J Hum Genet; 2013 Jul; 93(1):173-80. PubMed ID: 23791108
[TBL] [Abstract][Full Text] [Related]
4. Spectrum of mutations and genotype-phenotype analysis in Noonan syndrome patients with RIT1 mutations.
Yaoita M; Niihori T; Mizuno S; Okamoto N; Hayashi S; Watanabe A; Yokozawa M; Suzumura H; Nakahara A; Nakano Y; Hokosaki T; Ohmori A; Sawada H; Migita O; Mima A; Lapunzina P; Santos-Simarro F; García-Miñaúr S; Ogata T; Kawame H; Kurosawa K; Ohashi H; Inoue S; Matsubara Y; Kure S; Aoki Y
Hum Genet; 2016 Feb; 135(2):209-22. PubMed ID: 26714497
[TBL] [Abstract][Full Text] [Related]
5. Further evidence of the importance of RIT1 in Noonan syndrome.
Bertola DR; Yamamoto GL; Almeida TF; Buscarilli M; Jorge AA; Malaquias AC; Kim CA; Takahashi VN; Passos-Bueno MR; Pereira AC
Am J Med Genet A; 2014 Nov; 164A(11):2952-7. PubMed ID: 25124994
[TBL] [Abstract][Full Text] [Related]
6. Genotype and phenotype in patients with Noonan syndrome and a RIT1 mutation.
Kouz K; Lissewski C; Spranger S; Mitter D; Riess A; Lopez-Gonzalez V; Lüttgen S; Aydin H; von Deimling F; Evers C; Hahn A; Hempel M; Issa U; Kahlert AK; Lieb A; Villavicencio-Lorini P; Ballesta-Martinez MJ; Nampoothiri S; Ovens-Raeder A; Puchmajerová A; Satanovskij R; Seidel H; Unkelbach S; Zabel B; Kutsche K; Zenker M
Genet Med; 2016 Dec; 18(12):1226-1234. PubMed ID: 27101134
[TBL] [Abstract][Full Text] [Related]
7. [RIT1: a novel gene associated with Noonan syndrome].
Arroyo-Carrera I; Solo de Zaldivar-Tristancho M; Martin-Fernandez R; Vera-Torres M; Gonzalez de Buitrago-Amigo JF; Botet-Rodriguez J
Rev Neurol; 2016 Oct; 63(8):358-362. PubMed ID: 27699752
[TBL] [Abstract][Full Text] [Related]
8. Biochemical Classification of Disease-associated Mutants of RAS-like Protein Expressed in Many Tissues (RIT1).
Fang Z; Marshall CB; Yin JC; Mazhab-Jafari MT; Gasmi-Seabrook GM; Smith MJ; Nishikawa T; Xu Y; Neel BG; Ikura M
J Biol Chem; 2016 Jul; 291(30):15641-52. PubMed ID: 27226556
[TBL] [Abstract][Full Text] [Related]
9. Noonan syndrome caused by RIT1 gene mutation: A case report and literature review.
Zha P; Kong Y; Wang L; Wang Y; Qing Q; Dai L
Front Pediatr; 2022; 10():934808. PubMed ID: 36160792
[TBL] [Abstract][Full Text] [Related]
10. Mutations in RIT1 cause Noonan syndrome with possible juvenile myelomonocytic leukemia but are not involved in acute lymphoblastic leukemia.
Cavé H; Caye A; Ghedira N; Capri Y; Pouvreau N; Fillot N; Trimouille A; Vignal C; Fenneteau O; Alembik Y; Alessandri JL; Blanchet P; Boute O; Bouvagnet P; David A; Dieux Coeslier A; Doray B; Dulac O; Drouin-Garraud V; Gérard M; Héron D; Isidor B; Lacombe D; Lyonnet S; Perrin L; Rio M; Roume J; Sauvion S; Toutain A; Vincent-Delorme C; Willems M; Baumann C; Verloes A
Eur J Hum Genet; 2016 Aug; 24(8):1124-31. PubMed ID: 26757980
[TBL] [Abstract][Full Text] [Related]
11. Expanding the cardiac spectrum of Noonan syndrome with RIT1 variant: Left main coronary artery atresia causing sudden death.
Ramond F; Duband S; Croisille P; Cavé H; Teyssier G; Adouard V; Touraine R
Eur J Med Genet; 2017 Jun; 60(6):299-302. PubMed ID: 28347726
[TBL] [Abstract][Full Text] [Related]
12. RIT1 oncoproteins escape LZTR1-mediated proteolysis.
Castel P; Cheng A; Cuevas-Navarro A; Everman DB; Papageorge AG; Simanshu DK; Tankka A; Galeas J; Urisman A; McCormick F
Science; 2019 Mar; 363(6432):1226-1230. PubMed ID: 30872527
[TBL] [Abstract][Full Text] [Related]
13. Next-generation sequencing identifies rare variants associated with Noonan syndrome.
Chen PC; Yin J; Yu HW; Yuan T; Fernandez M; Yung CK; Trinh QM; Peltekova VD; Reid JG; Tworog-Dube E; Morgan MB; Muzny DM; Stein L; McPherson JD; Roberts AE; Gibbs RA; Neel BG; Kucherlapati R
Proc Natl Acad Sci U S A; 2014 Aug; 111(31):11473-8. PubMed ID: 25049390
[TBL] [Abstract][Full Text] [Related]
14. Two cases of RIT1 associated Noonan syndrome: Further delineation of the clinical phenotype and review of the literature.
Milosavljević D; Overwater E; Tamminga S; de Boer K; Elting MW; van Hoorn ME; Rinne T; Houweling AC
Am J Med Genet A; 2016 Jul; 170(7):1874-80. PubMed ID: 27109146
[TBL] [Abstract][Full Text] [Related]
15. MEK-ERK pathway modulation ameliorates disease phenotypes in a mouse model of Noonan syndrome associated with the Raf1(L613V) mutation.
Wu X; Simpson J; Hong JH; Kim KH; Thavarajah NK; Backx PH; Neel BG; Araki T
J Clin Invest; 2011 Mar; 121(3):1009-25. PubMed ID: 21339642
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular disease in Noonan syndrome.
Pierpont ME; Digilio MC
Curr Opin Pediatr; 2018 Oct; 30(5):601-608. PubMed ID: 30024444
[TBL] [Abstract][Full Text] [Related]
17. A novel RIT1 mutation causes deterioration of Noonan syndrome-associated cardiac hypertrophy.
Cai J; Li H
EBioMedicine; 2019 Apr; 42():6-7. PubMed ID: 30904604
[No Abstract] [Full Text] [Related]
18. Discrete effects of A57G-myosin essential light chain mutation associated with familial hypertrophic cardiomyopathy.
Kazmierczak K; Paulino EC; Huang W; Muthu P; Liang J; Yuan CC; Rojas AI; Hare JM; Szczesna-Cordary D
Am J Physiol Heart Circ Physiol; 2013 Aug; 305(4):H575-89. PubMed ID: 23748425
[TBL] [Abstract][Full Text] [Related]
19. Mutations in RIT1 cause Noonan syndrome - additional functional evidence and expanding the clinical phenotype.
Koenighofer M; Hung CY; McCauley JL; Dallman J; Back EJ; Mihalek I; Gripp KW; Sol-Church K; Rusconi P; Zhang Z; Shi GX; Andres DA; Bodamer OA
Clin Genet; 2016 Mar; 89(3):359-66. PubMed ID: 25959749
[TBL] [Abstract][Full Text] [Related]
20. RAS-dependent RAF-MAPK hyperactivation by pathogenic RIT1 is a therapeutic target in Noonan syndrome-associated cardiac hypertrophy.
Cuevas-Navarro A; Wagner M; Van R; Swain M; Mo S; Columbus J; Allison MR; Cheng A; Messing S; Turbyville TJ; Simanshu DK; Sale MJ; McCormick F; Stephen AG; Castel P
Sci Adv; 2023 Jul; 9(28):eadf4766. PubMed ID: 37450595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
